Lindsay L Peterson1, Seho Park2,3, Yikyung Park2, Graham A Colditz2, Narges Anbardar4,5, David P Turner5. 1. Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. 2. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. 3. Division of Breast Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea. 4. Harvard University, Boston, Massachusetts. 5. Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina.
Abstract
BACKGROUND: Advanced glycation end products (AGEs) are reactive metabolites produced as a by-product of sugar metabolism and are consumed through the diet in high-fat and highly processed foods. They are associated with chronic inflammatory diseases, and evidence suggests that they play a role in carcinogenesis. The authors evaluated the association of dietary AGE intake and the risk of postmenopausal invasive breast cancer. METHODS: This was a prospective cohort study of 183,548 postmenopausal women in the National Institutes of Health-AARP Diet and Health Study. The main outcome was incident invasive breast cancer. AGE intake was estimated from food-frequency questionnaires. Incident breast cancer cases were identified through state cancer registries. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals for developing breast cancer according to AGE intake quintiles. Multivariable regression models were adjusted for breast cancer risk factors. RESULTS: The mean follow-up was 12.8 years, and 9851 breast cancers (1978 advanced stage) were identified. The median AGE daily intake was 5932 kilo units per 100 kilocalories (KU/1000 kcal). Women with higher intake tended to have lower education levels, higher body mass index, less physical activity, were current smokers, and had higher fat and meat intake. The highest quintile of AGE intake (compared with the lowest) was associated with an increased risk of breast cancer (HR, 1.09; 95% CI, 1.02-1.16; P = .03) after adjusting for breast cancer risk factors and particularly was associated with 37% of advanced-stage tumors (HR, 1.37; 95% CI, 1.09-1.74; P < .02) after adjusting for risk factors and fat and meat intake. CONCLUSIONS: Dietary AGEs may play a role in the development of postmenopausal breast cancer.
BACKGROUND: Advanced glycation end products (AGEs) are reactive metabolites produced as a by-product of sugar metabolism and are consumed through the diet in high-fat and highly processed foods. They are associated with chronic inflammatory diseases, and evidence suggests that they play a role in carcinogenesis. The authors evaluated the association of dietary AGE intake and the risk of postmenopausal invasive breast cancer. METHODS: This was a prospective cohort study of 183,548 postmenopausal women in the National Institutes of Health-AARP Diet and Health Study. The main outcome was incident invasive breast cancer. AGE intake was estimated from food-frequency questionnaires. Incident breast cancer cases were identified through state cancer registries. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals for developing breast cancer according to AGE intake quintiles. Multivariable regression models were adjusted for breast cancer risk factors. RESULTS: The mean follow-up was 12.8 years, and 9851 breast cancers (1978 advanced stage) were identified. The median AGE daily intake was 5932 kilo units per 100 kilocalories (KU/1000 kcal). Women with higher intake tended to have lower education levels, higher body mass index, less physical activity, were current smokers, and had higher fat and meat intake. The highest quintile of AGE intake (compared with the lowest) was associated with an increased risk of breast cancer (HR, 1.09; 95% CI, 1.02-1.16; P = .03) after adjusting for breast cancer risk factors and particularly was associated with 37% of advanced-stage tumors (HR, 1.37; 95% CI, 1.09-1.74; P < .02) after adjusting for risk factors and fat and meat intake. CONCLUSIONS: Dietary AGEs may play a role in the development of postmenopausal breast cancer.
Authors: A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis Journal: Am J Epidemiol Date: 2001-12-15 Impact factor: 4.897
Authors: Li Jiao; Rachael Stolzenberg-Solomon; Thea Palmer Zimmerman; Zhigang Duan; Liang Chen; Lisa Kahle; Adam Risch; Amy F Subar; Amanda J Cross; Albert Hollenbeck; Helen Vlassara; Gary Striker; Rashmi Sinha Journal: Am J Clin Nutr Date: 2014-11-19 Impact factor: 7.045
Authors: P Tesarová; M Kalousová; B Trnková; J Soukupová; S Argalásová; O Mestek; L Petruzelka; T Zima Journal: Neoplasma Date: 2007 Impact factor: 2.575
Authors: Kyung Jin Lee; Ji Won Yoo; Yun Kyu Kim; Jae Ho Choi; Tae-Yong Ha; Minchan Gil Journal: Biochem Biophys Res Commun Date: 2017-12-02 Impact factor: 3.575
Authors: Armand M A Linkens; Niels van Best; Petra M Niessen; Nicole E G Wijckmans; Erica E C de Goei; Jean L J M Scheijen; Martien C J M van Dongen; Christel C J A W van Gool; Willem M de Vos; Alfons J H M Houben; Coen D A Stehouwer; Simone J M P Eussen; John Penders; Casper G Schalkwijk Journal: Int J Mol Sci Date: 2022-05-10 Impact factor: 6.208
Authors: Omonefe O Omofuma; Lindsay L Peterson; David P Turner; Anwar T Merchant; Jiajia Zhang; Cynthia A Thomson; Marian L Neuhouser; Linda G Snetselaar; Bette J Caan; Aladdin H Shadyab; Nazmus Saquib; Hailey R Banack; Jaime Uribarri; Susan E Steck Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-09-28 Impact factor: 4.090
Authors: Bradley A Krisanits; Pamela Woods; Lourdes M Nogueira; Demarcus D Woolfork; Courtney E Lloyd; Andrew Baldwin; Callan C Frye; Kendell D Peterson; Sean D Cosh; Qi-Jin Guo; Laura S Spruill; Michael B Lilly; Kristi Helke; Hong Li; George S Hanna; Mark T Hamann; Courtney Thomas; Mahtabuddin Ahmed; Monika B Gooz; Victoria J Findlay; David P Turner Journal: Transl Oncol Date: 2022-01-25 Impact factor: 4.243
Authors: Armand Ma Linkens; Alfons Jhm Houben; Petra M Niessen; Nicole Eg Wijckmans; Erica Ec de Goei; Mathias Dg Van den Eynde; Jean Ljm Scheijen; Marjo Ph van den Waarenburg; Andrea Mari; Tos Tjm Berendschot; Lukas Streese; Henner Hanssen; Martien Cjm van Dongen; Christel Cjaw van Gool; Coen DA Stehouwer; Simone Jmp Eussen; Casper G Schalkwijk Journal: JCI Insight Date: 2022-03-22
Authors: Mathew J Gregoski; Janis Newton; Kathleen Blaylock; Sheila A O Smith; David P Turner Journal: Int J Environ Res Public Health Date: 2021-05-02 Impact factor: 3.390